Text Size

Cognitive Correlates of Substance Abuse, Part 2 - 16

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2002 by National Institute on Drug Abuse (NIDA).
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00000351
First received: September 20, 1999
Last updated: June 23, 2005
Last verified: December 2002
History of Changes
  Purpose

Part II: Examine cognitive performance of stimulant abusers (methamphetamine and cocaine) during recovery by assessing their cognitive function at monthly intervals.


Condition Phase
Amphetamine-Related Disorders
 Phase 4

Study Type: Observational
Study Design: Time Perspective: Cross-Sectional
Official Title: Cognitive Correlates of Substance Abuse, Part 2

Resource links provided by NLM:

MedlinePlus related topics: Methamphetamine
U.S. FDA Resources

Further study details as provided by National Institute on Drug Abuse (NIDA):

Estimated Enrollment: 43
Detailed Description:

Part II: Examine cognitive performance of stimulant abusers (methamphetamine and cocaine) during recovery by assessing their cognitive function at monthly intervals.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Please contact site for information

Inclusion Criteria:

M/F. Meet DSM-IV criteria for stimulant dependence. Agree to conditions of the study and sign informed consent.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00000351

Locations
United States, California
Friends Research Institute
Los Angeles, California, United States, 90025
Sponsors and Collaborators
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Walter Ling, M.D. Friends Research Institute, Inc.
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00000351     History of Changes
Other Study ID Numbers: NIDA-3-0010-16
Study First Received: September 20, 1999
Last Updated: June 23, 2005
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Amphetamine-Related Disorders
Substance-Related Disorders
Mental Disorders

ClinicalTrials.gov processed this record on May 19, 2013